RAPT FY 2020 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$5M100.0% margin

Operating Income

-$53M-1055.4% margin

Net Income

-$53M-1049.0% margin

EPS (Diluted)

$-17.53

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$41M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$119M

Total Liabilities

$15M

Stockholders' Equity

$104M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$0	—
Gross Profit	$5M	-$1M	+479.1%
Operating Income	-$53M	-$44M	-22.0%
Net Income	-$53M	-$43M	-23.0%